| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6207661 | BAXTER HLTHCARE CORP | Premixed formulation of piperacillin sodium and tazobactam sodium injection |
Feb, 2019
(5 years ago) | |
| US8133883 | BAXTER HLTHCARE CORP | Compositions containing piperacillin and tazobactam useful for injection |
Apr, 2023
(1 year, 7 days ago) | |
| US6900184 | BAXTER HLTHCARE CORP | Compositions containing pipercillin and tazobactam useful for injection |
Apr, 2023
(1 year, 7 days ago) | |
| US7915229 | BAXTER HLTHCARE CORP | Compositions containing piperacillin and tazobactam useful for injection |
Apr, 2023
(1 year, 7 days ago) | |
Zosyn In Plastic Container is owned by Baxter Hlthcare Corp.
Zosyn In Plastic Container contains Piperacillin Sodium; Tazobactam Sodium.
Zosyn In Plastic Container has a total of 4 drug patents out of which 4 drug patents have expired.
Expired drug patents of Zosyn In Plastic Container are:
- US6207661
- US8133883
- US6900184
- US7915229
Zosyn In Plastic Container was authorised for market use on 24 February, 1998.
Zosyn In Plastic Container is available in injectable;injection dosage forms.
Zosyn In Plastic Container can be used as method of treating bacterial infections.
The generics of Zosyn In Plastic Container are possible to be released after 14 April, 2023.
Drugs and Companies using PIPERACILLIN SODIUM; TAZOBACTAM SODIUM ingredient
Market Authorisation Date: 24 February, 1998
Treatment: Method of treating bacterial infections
Dosage: INJECTABLE;INJECTION
ZOSYN IN PLASTIC CONTAINER family patents
